...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Homology modeling and structural analysis of 11beta-hydroxysteroid dehydrogenase type 2.
【24h】

Homology modeling and structural analysis of 11beta-hydroxysteroid dehydrogenase type 2.

机译:2 型 11β-羟基类固醇脱氢酶的同源建模和结构分析。

获取原文
获取原文并翻译 | 示例
           

摘要

11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) was homology-modeled by a Boltzmann-weighted randomized modeling procedure, using the X-ray crystal structure of 11betaHSD1 (PDB code: 3HFG) as a template. The model exhibited significant 3D similarities to 11betaHSD1. The contact energy profiles of the 11betaHSD2 model were in good agreement with that of the X-ray structure of 11betaHSD1. The secondary structure of the 11betaHSD2 model exhibited a central 6-stranded all-parallel beta-sheet sandwich-like structure, flanked on both sides by 3-helices. Ramachandran plots revealed that only 1.9 of the amino acid residues were in the disfavored region for 11betaHSD2. Furthermore, the ligand-binding site (LBS) volume was calculated to be 845 A(3), which suggests that the LBS of 11betaHSD2 is sufficiently large to contain cofactors and substrates (ligands), such as NAD(+) and cortisol. The electrostatic analysis revealed that the 11betaHSD2 model had a positive potential at the LBS, which indicates that 11betaHSD2 possibly attracts negatively charged ligands at the LBS. These results indicate that the model was successfully evaluated and analyzed. Consequently, it is proposed that the 11betaHSD2 model in the present study will be suitable for further in silico structure-based de novo antitumor drug designing. To the best of our knowledge, this is the latest report of an accurate 11betaHSD2 model to target 11betaHSD2 for the development of anticancer drugs.
机译:以11betaHSD1(PDB代码:3HFG)的X射线晶体结构为模板,采用玻尔兹曼加权随机建模程序对2型11β-羟基类固醇脱氢酶2型(11betaHSD2)进行同源建模。该模型与 11betaHSD1 表现出显着的 3D 相似性。11betaHSD2模型的接触能分布与11betaHSD1的X射线结构吻合较好。11betaHSD2模型的二级结构表现为中央6链全平行β-折叠三明治状结构,两侧为3螺旋。Ramachandran 图显示,只有 1.9% 的氨基酸残基位于 11betaHSD2 的不利区域。此外,配体结合位点 (LBS) 体积计算为 845 A(3),这表明 11betaHSD2 的 LBS 足够大以包含辅因子和底物(配体),例如 NAD(+) 和皮质醇。静电分析表明,11betaHSD2模型在LBS处具有正电位,这表明11betaHSD2可能在LBS处吸引带负电的配体。这些结果表明,该模型已经成功评估和分析。因此,提出本研究中的11betaHSD2模型将适用于进一步基于计算机结构的从头抗肿瘤药物设计。据我们所知,这是针对 11betaHSD2 开发抗癌药物的准确 11betaHSD2 模型的最新报告。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号